XENOPORT
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizantยฎ (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regniteยฎ (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
XENOPORT
Industry:
Biotechnology Developer Platform Pharmaceutical
Founded:
1999-01-01
Address:
Santa Clara, California, United States
Country:
United States
Website Url:
http://www.xenoport.com
Total Employee:
251+
Status:
Active
Contact:
14086167210
Email Addresses:
[email protected]
Total Funding:
143.77 M USD
Technology used in webpage:
GStatic Google Static Content Register.com DNS Network Solutions Omniture SiteCatalyst Cogent Communications Edgar Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
GGV Capital
GGV Capital investment in Series D - Xenoport
GGV Capital
GGV Capital investment in Series C - Xenoport
Venrock
Venrock investment in Series C - Xenoport
Venrock
Venrock investment in Series B - Xenoport
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Xenoport
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Xenoport
Venrock
Venrock investment in Series A - Xenoport
Skyline Ventures
Skyline Ventures investment in Series A - Xenoport
Alejandro Zaffaroni
Alejandro Zaffaroni investment in Series A - Xenoport
CMEA Ventures
CMEA Ventures investment in Series A - Xenoport
Official Site Inspections
http://www.xenoport.com
- Host name: 172.67.137.43
- IP address: 172.67.137.43
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago